Neurobiology of schizophrenia: from outcome to pathophysiological insights.
作者信息
Falkai P, Möller H-J
出版信息
Eur Arch Psychiatry Clin Neurosci. 2012 Mar;262(2):93-4. doi: 10.1007/s00406-012-0294-y.
Abstract
摘要
相似文献
1
Neurobiology of schizophrenia: from outcome to pathophysiological insights.精神分裂症的神经生物学：从结局到病理生理学见解
Eur Arch Psychiatry Clin Neurosci. 2012 Mar;262(2):93-4. doi: 10.1007/s00406-012-0294-y.
2
Cognitive experimental approaches to investigating impaired cognition in schizophrenia: a paradigm shift.用于研究精神分裂症认知障碍的认知实验方法：范式转变。
J Clin Exp Neuropsychol. 2002 Oct;24(7):873-82. doi: 10.1076/jcen.24.7.873.8386.
3
Neurobiology and phenotypic expression in early onset schizophrenia.早发性精神分裂症的神经生物学和表型表达。
Early Interv Psychiatry. 2011 Feb;5(1):3-14. doi: 10.1111/j.1751-7893.2010.00253.x.
4
Cognitive impairment in schizophrenia: profile, course, and neurobiological determinants.精神分裂症中的认知障碍：特征、病程及神经生物学决定因素。
Handb Clin Neurol. 2012;106:433-45. doi: 10.1016/B978-0-444-52002-9.00025-5.
5
The neuropsychology and neurobiology of late-onset schizophrenia and very-late-onset schizophrenia-like psychosis: A critical review.迟发性精神分裂症和极晚发性精神分裂症样精神病的神经心理学和神经生物学：批判性综述。
Neurosci Biobehav Rev. 2017 Dec;83:604-621. doi: 10.1016/j.neubiorev.2017.08.024. Epub 2017 Sep 1.
6
[First conference. Neurobiology of schizophrenia].
Vertex. 2002;13 Suppl:5-15.
7
Phenomenology and neurobiology of self disorder in schizophrenia: Primary factors.精神分裂症中自我障碍的现象学与神经生物学：主要因素
Schizophr Res. 2015 Dec;169(1-3):464-473. doi: 10.1016/j.schres.2015.09.024. Epub 2015 Oct 26.
8
Measurement and Treatment Research to Improve Cognition in Schizophrenia: NIMH MATRICS initiative to support the development of agents for improving cognition in schizophrenia.改善精神分裂症认知功能的测量与治疗研究：美国国立精神卫生研究所（NIMH）的MATRICS计划，旨在支持开发改善精神分裂症认知功能的药物。
Schizophr Res. 2004 Dec 15;72(1):5-9. doi: 10.1016/j.schres.2004.09.010.
9
The molecular and cellular neurobiology of nicotine abuse in schizophrenia.精神分裂症中尼古丁滥用的分子与细胞神经生物学
Pharmacopsychiatry. 2008 Sep;41 Suppl 1:S51-9. doi: 10.1055/s-2008-1081463.
10
Where will insights into hippocampal activity in schizophrenia lead us?对精神分裂症中海马体活动的深入了解将把我们引向何方？
Expert Rev Neurother. 2010 Jan;10(1):1-4. doi: 10.1586/ern.09.145.
引用本文的文献
1
A three-month longitudinal study of changes in day/night serum total antioxidant capacity in paranoid schizophrenia.偏执型精神分裂症患者日间/夜间血清总抗氧化能力变化的三个月纵向研究。
PLoS One. 2017 Dec 8;12(12):e0189348. doi: 10.1371/journal.pone.0189348. eCollection 2017.
2
Bypassing P-Glycoprotein Drug Efflux Mechanisms: Possible Applications in Pharmacoresistant Schizophrenia Therapy.绕过P-糖蛋白药物外排机制：在耐药性精神分裂症治疗中的可能应用。
Biomed Res Int. 2015;2015:484963. doi: 10.1155/2015/484963. Epub 2015 Sep 27.
本文引用的文献
1
A promoter variant of SHANK1 affects auditory working memory in schizophrenia patients and in subjects clinically at risk for psychosis.SHANK1 启动子变异影响精神分裂症患者和临床精神病高危人群的听觉工作记忆。
Eur Arch Psychiatry Clin Neurosci. 2012 Mar;262(2):117-24. doi: 10.1007/s00406-011-0233-3. Epub 2011 Sep 7.
2
Descriptive analyses of the aripiprazole arm in the risperidone long-acting injectable versus quetiapine relapse prevention trial (ConstaTRE).利培酮长效注射剂与喹硫平预防复发试验（ConstaTRE）中阿立哌唑组的描述性分析。
Eur Arch Psychiatry Clin Neurosci. 2012 Mar;262(2):139-49. doi: 10.1007/s00406-011-0220-8. Epub 2011 Aug 2.
3
General and domain-specific neurocognitive impairments in deficit and non-deficit schizophrenia.一般和特定领域的神经认知损伤在缺陷型和非缺陷型精神分裂症中。
Eur Arch Psychiatry Clin Neurosci. 2012 Mar;262(2):107-15. doi: 10.1007/s00406-011-0224-4. Epub 2011 Jul 27.
4
Critical trial-related criteria in acute schizophrenia studies.急性精神分裂症研究中的关键试验相关标准。
Eur Arch Psychiatry Clin Neurosci. 2012 Mar;262(2):151-5. doi: 10.1007/s00406-011-0225-3. Epub 2011 Jul 26.
5
Investigation of schizophrenic patients from Istanbul, Turkey for the presence of West Nile virus.调查来自土耳其伊斯坦布尔的精神分裂症患者是否存在西尼罗河病毒。
Eur Arch Psychiatry Clin Neurosci. 2012 Mar;262(2):173-7. doi: 10.1007/s00406-011-0222-6. Epub 2011 Jul 2.
6
Characterization of spontaneous Parkinsonism in drug-naive patients with nonaffective psychotic disorders.描述非情感性精神病障碍的药物初治患者中自发性帕金森病的特征。
Eur Arch Psychiatry Clin Neurosci. 2012 Mar;262(2):131-8. doi: 10.1007/s00406-011-0219-1. Epub 2011 May 28.
7
Similarities in early course among men and women with a first episode of schizophrenia and schizophreniform disorder.首发精神分裂症和分裂情感性障碍患者早期病程的相似性。
Eur Arch Psychiatry Clin Neurosci. 2012 Mar;262(2):95-105. doi: 10.1007/s00406-011-0218-2. Epub 2011 May 26.
8
Differential expression of HINT1 in schizophrenia brain tissue.HINT1 在精神分裂症脑组织中的差异表达。
Eur Arch Psychiatry Clin Neurosci. 2012 Mar;262(2):167-72. doi: 10.1007/s00406-011-0216-4. Epub 2011 May 8.
9
Caregiver burden in chronic mental illness: the role of patient and caregiver characteristics.慢性精神疾病患者照料者负担：患者和照料者特征的作用。
Eur Arch Psychiatry Clin Neurosci. 2012 Mar;262(2):157-66. doi: 10.1007/s00406-011-0215-5. Epub 2011 May 3.
10
Dissociable and common deficits in inhibitory control in schizophrenia and bipolar disorder.精神分裂症和双相情感障碍中抑制控制的可分离和共同缺陷。
Eur Arch Psychiatry Clin Neurosci. 2012 Mar;262(2):125-30. doi: 10.1007/s00406-011-0213-7. Epub 2011 Apr 22.
Zotero 插件